USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18005
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMacovenciuc, Alina
dc.contributor.authorCernei, Irina
dc.date.accessioned2021-09-27T13:59:16Z
dc.date.available2021-09-27T13:59:16Z
dc.date.issued2021
dc.identifier.citationMACOVENCIUC, Alina, CERNEI, Irina. Cognitive impairment and neuropsychiatric manifestations at the onset of multiple sclerosis: case report. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 23. ISSN 2537-6381.
dc.identifier.issn2537-6381
dc.identifier.issn2537-6373
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18005
dc.description.abstractBackground: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that mainly affects young adults and leads to a wide range of signs and symptoms, including physical, cognitive and psychiatric manifestations. The cognitive manifestations are slow processing speed, reduced memory and attention performance. Psychiatric disorders include depression, anxiety, bipolar disorder, and psychosis. The first manifestations of the disease are various and sometimes atypical, they can also mimic any other condition. Material and methods: Case report of early atypical manifestations of MS. Results: A 26-year-old man presented with diplopia, cognitive decline (inattention and episodes of memory loss) and psychiatric impairment, rapidly progressing during the last 6 months. Dysphoria and anxiety appeared after the cognitive decline. Initially the patient was considered to suffer from a psychiatric disorder, but treatment with anticonvulsants (valproic acid) didn’t produce any effect. Neurological examination revealed generalized hyperreflexia, a left pyramidal syndrome and diplopia. Brain MRI demonstrated multiple contrast enhanced ring like lesions (~ N10) in the periventricular and juxtacortical white matter, cerebellum, brainstem, genu of the corpus callosum and cervical spinal cord. Cerebrospinal fluid evaluation demonstrated a presence of specific oligoclonal bands. The treatment with methylprednisolone 1g/day for 5 days suppressed the psychiatric and cognitive manifestations. The patient was referred to disease modifying treatment. Conclusions: Recognition of early atypical manifestations of MS such as cognitive impairment and psychiatric disorders is important to avoid diagnostic errors and inappropriate, potentially harmful treatments.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofThe Moldovan Medical Journalen_US
dc.subjectmultiple sclerosisen_US
dc.subjectcognitive declineen_US
dc.subjectneuropsychiatric manifestationsen_US
dc.titleCognitive impairment and neuropsychiatric manifestations at the onset of multiple sclerosis: case reporten_US
dc.typeOtheren_US
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
Cognitive_impairment_and_neuropsychiatric_manifestations_at_the_onset_of.pdf77.96 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback